Related Experiment Video

Updated: Feb 26, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.6K

Thirty-Day Readmissions for Critical Limb Ischemia: Ready for a New Quality Metric?

Patrick M Looser1, Dmitriy N Feldman2

  • 1From Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York.

Circulation
|July 12, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Editorialscritical limb ischemiapatient readmissionperipheral arterial disease

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.8K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

689

Related Experiment Videos

Last Updated: Feb 26, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.6K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.8K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

689

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

433
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

462
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
462

Articles linked to this work by shared authors, journal, and citation graph.

Diagnosis and management of ACS in patients with ESRD on haemodialysis: a comprehensive review.

The British journal of cardiology·2026

Precision approach for transradial access during PCI: a state-of-the-art review.

Frontiers in cardiovascular medicine·2026

2025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous Disease: This statement was endorsed by the Society for Vascular Medicine (SVM).

Journal of the Society for Cardiovascular Angiography & Interventions·2025

Daylight Savings Time and Acute Myocardial Infarction.

JAMA network open·2025

Current State of Simulation in Interventional Cardiology Training: Results of a SCAI Survey.

Journal of the Society for Cardiovascular Angiography & Interventions·2025

Renal Denervation: A Review of Current Devices, Techniques, and Evidence.

Interventional cardiology clinics·2025

Immune Checkpoint Inhibitor Myocarditis and Myotoxicity.

Circulation·2026

Impaired Glycolysis Leads to Defective Efferocytosis and Impaired Plaque Resolution in Tet2 Clonal Hematopoiesis.

Circulation·2026

Macrotroponin Complexes and Risk of Cardiovascular Events.

Circulation·2026

Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy.

Circulation·2026

Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association.

Circulation·2026

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

Circulation·2026

Histopathologic categories of gastrointestinal tract vascular disorders: A review and update.

Seminars in diagnostic pathology·2026

Pulmonary Complications in Acute Myelogenous Leukemia in the Post-Allogeneic Hematopoietic Stem Cell Transplant Period: Diagnostic Yield of Bronchoalveolar Lavage and Biopsy: A Single-Center Experience.

Transplantation proceedings·2026

Healthcare costs of recurrent acute pancreatitis hospitalizations.

Journal of clinical lipidology·2026

Nimodipine in catheter flush solutions is associated with reduced vasospasm risk in endovascular stroke treatment.

Journal of neurointerventional surgery·2026

Multidisciplinary management of an older adult with vascular Ehlers-Danlos syndrome and multiple autoimmune comorbidities.

BMJ case reports·2026

Managing thrombotic risk in myeloproliferative disorders.

Expert review of hematology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us